The FDA did not request additional clinical or non-clinical data US regulators have refused to file Bristol Myers Squibb and bluebird bio’s marketing application seeking approval of idecabtagene ...

Bristol-Myer Squibb has only just won FDA approval for its CAR-T Breyanzi in large B-cell lymphoma (LBCL), but is already eyeing an expansion into earlier-line therapy that could overtake rival ...

Drugmaker Bristol-Myers Squibb and a biotech company with which it has partnered have sent their application to the Food and Drug Administration seeking approval for what could become the first ...

NITI Aayog and the Department of Science & Technology (DST) have started working with the EV industry and academia on developing an open-source BMS for two- and three-wheeler EVs: Report An Open-BMS ...